SOLVO Management

Ernő Duda president & CEO
Peter Krajcsi Dr. Chief Scientific Officer
Berend Oosterhuis Business Development Director
Szabolcs Hajdú Chief Financial Officer

Ernő Duda

Founder, president & CEO
Tel: +36 62 424 729

Fax: +36 62 420 617

Also Founder and president of the Hungarian Biotechnology Association, a representative organization active in lobbying for the interests of its member companies and the biotechnology sector in Hungary. As a genuine entrepreneur, he has founded or co-founded 13 companies over the past 15 years, including a corporate finance consulting company focused on high-tech Hungarian start-ups, and Hungary's largest online second-hand book store. He was Vice president of the American Chamber of Commerce in Hungary for 2 years, and president of the Junior Achievement Foundation Hungary from 1997 until 2006. Mr. Duda is a member of the Research and Technology Innovation Council of the National Office for Research and Technology, the Board of Trustees of the Bay Zoltán Foundation for Applied Research, and the Board of the Hungarian Association for Innovation. Besides running a course at the University of Szeged, he regularly holds presentations at conferences and various public events. He has been awarded the Order of Merit of the Republic of Hungary for his distinguished contribution to the development of the Hungarian biotechnology industry.

Péter Krajcsi, Ph.D.

Chief Scientific Officer
Tel: +36 23 503 940

Fax: +36 23 503 941

Associate professor at the Dept. of Medical Biochemistry of the Semmelweis University Medical School, Budapest, Hungary since 1994. Before joining SOLVO Biotechnology in 2002, he worked as Director of Biology at ComGenex Inc., Budapest, Hungary. He was Senior Scientist of VirRex LLC, St. Louis, MO, USA between 2000 and 2001, and worked as Head of the Department of Molecular Cell Biology and Biochemistry at Biorex R&D Co. Hungary between 1998 and 1999. Before 1998, he held various academic positions in Hungary and in the United States, among them position of Visiting Scientist at Northwestern University, Dept. of pathology, Chicago, IL, USA; and Visiting Research Associate at the Inst. for Molecular Virology, St. Louis University Medical School, St. Louis, MO. USA. Dr. Krajcsi has a ph.D. in Molecular Cell Biology and in Biochemistry. He has published over 50 articles in peer-reviewed scientific journals and is an author on two scientific textbooks.

Berend Oosterhuis

Business Development Director
Tel: +36 23 503 940

Fax: +36 23 503 941

Mr. Oosterhuis began his career at SOLVO in 2005 as a scientist in the Research and Development Laboratory, where he worked on various research projects and was involved in the publication of several scientific papers. Before promoted to BD Director, he served as the Head of the Service Laboratory, and gained valuable knowledge about the ADME-Tox market and the role of transporter proteins in it.

Mr. Oosterhuis holds a Master’s Degree in Biotechnology from the Wageningen University and Research Centre.

Szabolcs Hajdú

Chief Financial Officer
Tel: +36 62 424 729

Fax: +36 62 420 617

Before joining SOLVO Biotechnology in 2008, Mr. Hajdú worked as Financial Director of Főszer-Electric Zrt. (2001-2008), where his responsibilities included managing IT, logistics and finance activities, among others development of liquidity management; development and improvement of controlling organisation; project management of significant- multinational projects; coordination of internal development and investment areas; management of tenders; representation of the company in professional organisations; coordination of activities of affiliates; development of professional trainings. Mr. Hajdú obtained his Degree as Programmer Mathematician from József Attila University-Faculty of Science, as Economist and Accountant from College of Finance and Accountings and as Economist in specialization of Enterprise Development from University of Szeged-Faculty of Economics and Business Administration.

This page contains information about following topics: Transporter absorption, Preclinical assay, DMPK, Digoxin assessment, Verapamil, Transporter drug-drug interaction.